ATE429904T1 - Topisch anwendbare arzneipräparate und verfahren zur behandlung - Google Patents

Topisch anwendbare arzneipräparate und verfahren zur behandlung

Info

Publication number
ATE429904T1
ATE429904T1 AT01945471T AT01945471T ATE429904T1 AT E429904 T1 ATE429904 T1 AT E429904T1 AT 01945471 T AT01945471 T AT 01945471T AT 01945471 T AT01945471 T AT 01945471T AT E429904 T1 ATE429904 T1 AT E429904T1
Authority
AT
Austria
Prior art keywords
formulation
treatment
methods
therapeutic agent
unit dose
Prior art date
Application number
AT01945471T
Other languages
German (de)
English (en)
Inventor
John Nicholas Staniforth
Michael John Tobyn
Original Assignee
Pharmakodex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmakodex Ltd filed Critical Pharmakodex Ltd
Application granted granted Critical
Publication of ATE429904T1 publication Critical patent/ATE429904T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT01945471T 2000-06-26 2001-06-26 Topisch anwendbare arzneipräparate und verfahren zur behandlung ATE429904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015617.4A GB0015617D0 (en) 2000-06-26 2000-06-26 Improved preparations for dermal delivery of active substances
PCT/GB2001/002823 WO2002000203A1 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment

Publications (1)

Publication Number Publication Date
ATE429904T1 true ATE429904T1 (de) 2009-05-15

Family

ID=9894412

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945471T ATE429904T1 (de) 2000-06-26 2001-06-26 Topisch anwendbare arzneipräparate und verfahren zur behandlung

Country Status (20)

Country Link
US (3) US7754240B2 (enExample)
EP (2) EP1296652B1 (enExample)
JP (1) JP2004501185A (enExample)
KR (1) KR20030041871A (enExample)
CN (1) CN1438878A (enExample)
AT (1) ATE429904T1 (enExample)
AU (2) AU2001267686A1 (enExample)
BR (1) BR0112356A (enExample)
CA (1) CA2413699C (enExample)
DE (1) DE60138547D1 (enExample)
DK (1) DK1296652T3 (enExample)
ES (1) ES2325980T3 (enExample)
GB (1) GB0015617D0 (enExample)
HU (1) HUP0301121A3 (enExample)
IL (1) IL153665A0 (enExample)
MX (1) MXPA02012666A (enExample)
NO (1) NO333292B1 (enExample)
PL (1) PL211890B1 (enExample)
WO (1) WO2002000203A1 (enExample)
ZA (1) ZA200210224B (enExample)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
GB2383950B (en) * 2002-01-11 2006-01-18 Cosmetic Warriors Ltd Cosmetic product
AU2003223005A1 (en) 2002-05-06 2003-11-17 Vectura Limited Application device for topical administration of pharmaceutical agents
US20070065463A1 (en) 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
US7718674B2 (en) * 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
DE102004059613A1 (de) * 2004-12-10 2006-06-14 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer topischen Therapie von Neurodermitis
GB0524961D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents for systemic effect
GB0524959D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Topical compositions for treatment of respiratory disorders
US20090215753A1 (en) * 2005-12-07 2009-08-27 Pharmacodex Ltd. Topical Compositions for Paediatric Use
EP2206494B1 (en) 2006-03-31 2015-12-02 Stiefel Research Australia Pty Ltd Foamable suspension gel
GB0612556D0 (en) * 2006-06-23 2006-08-02 Univ Aston Topical pharmaceutical formulations
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008011161A2 (en) * 2006-07-21 2008-01-24 Bridge Pharma, Inc. Dermal anesthetic compounds
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
CA2689472C (en) * 2008-07-18 2019-01-15 Karine Theberge Articles of manufacture releasing an active ingredient
ES2400210T3 (es) 2008-10-02 2013-04-08 Mylan Inc. Método para preparar un laminado de adhesivo multicapa
JP5913095B2 (ja) 2009-06-26 2016-04-27 タリス バイオメディカル エルエルシー 植込み型薬物送達装置及びその作製方法
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
EP2593185A1 (en) 2010-07-17 2013-05-22 Merck Patent GmbH Enhancement of penetration and action
EP2441444A1 (en) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
SG189350A1 (en) 2010-10-15 2013-05-31 Procter & Gamble Use of monoamine oxidase inhibitors to improve epithelial biology
US8293288B2 (en) 2011-02-23 2012-10-23 Edna Ma Pain relieving composition
US8512768B2 (en) 2011-02-23 2013-08-20 Miss Smarty Pants Enterprises, Inc. Pain relieving composition
MX368747B (es) 2011-05-10 2019-10-14 Itochu Chemical Frontier Corp Parche no acuoso de lidocaína y un agente de disolución que comprende un ácido orgánico y un polialcohol que están contenidos en un emplaste para usarse en el tratamiento de dolor muscular a través de la piel.
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
SI2823815T1 (sl) 2011-09-27 2018-09-28 Itochu Chemical Frontier Corporation Ne-vodni obliž
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
CN102641275B (zh) * 2012-05-16 2013-04-24 江苏圣宝罗药业有限公司 复方丙酸氯倍他索与维a酸软膏剂
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
CA2903020C (en) * 2013-02-28 2019-06-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
JP6517186B2 (ja) 2013-03-15 2019-05-22 タリス バイオメディカル エルエルシー 薬物透過性構成部材を備えた薬物送達デバイス、及び方法
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
CA2919215C (en) 2013-08-19 2022-11-29 Taris Biomedical Llc Multi-unit drug delivery devices and methods
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
AU2015290098B2 (en) 2014-07-17 2018-11-01 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
EP3273940B1 (en) 2015-03-23 2020-12-16 Biopharmx, Inc. Pharmaceutical tetracycline composition for dermatological use
US10894150B2 (en) 2015-04-23 2021-01-19 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
CN108853140A (zh) * 2018-07-18 2018-11-23 豆立忠 一种多药物模块软膏及其制备方法
WO2020049505A1 (en) 2018-09-06 2020-03-12 Innopharmascreen Inc. Methods and compositions for treatment of asthma or parkinson's disease
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN112237547B (zh) * 2020-09-28 2022-08-30 安徽美邸康药业有限公司 一种药贴成型装置
MX2020011523A (es) * 2020-10-29 2022-05-02 Exeltis Pharma Mexico S A De C V Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma.
BE1028968B1 (nl) 2020-12-29 2022-08-01 Usocore Nv Harde was zonder BHT
WO2024064151A1 (en) * 2022-09-21 2024-03-28 The Board Of Trustees Of The Leland Stanford Junior University Synergistic stimulation of mucociliary clearance to treat mucus obstruction in cystic fibrosis and other muco-obstructive disorders

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US369784A (en) * 1887-09-13 fueman
US308343A (en) * 1884-11-25 Pail handle
US151274A (en) * 1874-05-26 Improvement in springs for vehicles
US597849A (en) * 1898-01-25 Ditching-jack
US765986A (en) * 1902-06-07 1904-07-26 Nat Tube Co Conical rolls for piercing, expanding, or cross-rolling metal billets or tubular blanks.
US863941A (en) * 1906-06-05 1907-08-20 James M Robbins Wheelwright-machine.
US892890A (en) * 1907-10-14 1908-07-07 Max A Repelow Card-index.
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
DE2551446B2 (de) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg Verfahren zur herstellung von suppositorien
CH637014A5 (de) * 1978-09-29 1983-07-15 Sandoz Ag Verfahren zur herstellung von suppositorien.
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
FR2515036B1 (fr) * 1981-10-23 1986-12-05 Oreal Composition stable a l'oxydation d'anthraline ou de l'un de ses derives et son utilisation dans le traitement des maladies de la peau
US4495203A (en) 1981-10-23 1985-01-22 Societe Anonyme Dite: L'oreal Anhydrous composition, stable to oxidation, based on anthralin or one of its derivatives, in a carrier consisting of a fatty acid alkyl ester and a thickener, and its use in the treatment of skin diseases
US4892890A (en) * 1984-11-01 1990-01-09 G. D. Searle And Company External analgesic compositions
DE3522060A1 (de) * 1985-06-20 1987-01-08 Liedtke Pharmed Gmbh Arzneipflaster fuer systemische anwendungen
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
FR2633187A1 (fr) 1988-06-23 1989-12-29 Gafner Paul Felix Dispositif applicateur cutane d'une solution medicamenteuse pour le traitement dermatologique
AU622961B2 (en) * 1988-12-23 1992-04-30 Westech Industrial Ltd. Flame arrester having detonation-attenuating means
LU87416A1 (fr) * 1988-12-29 1990-07-10 Cird Microgranules charges en une substance active,constitues essentiellement d'un triglyceride d'acides gras satures et leur utilisation par voie topique dans le domaine therapeutique
US5389686A (en) * 1989-02-20 1995-02-14 Jouveinal Sa Analgesic properties of fedotozine
FR2663007A1 (fr) 1990-06-08 1991-12-13 Kodak Pathe Emballage de produits photographiques en bandes.
US5121158A (en) * 1990-10-31 1992-06-09 Umax Data System Inc. Filter driving mechanism for color optical reader
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
JPH07258071A (ja) * 1994-03-22 1995-10-09 Ojiro Yukagaku Kenkyusho:Kk 粒状皮膚用剤およびその用途
US5597849A (en) * 1994-11-14 1997-01-28 Medical Polymer Technologies, Inc. Stick formulations for topical drug delivery of therapeutic agents and uses thereof
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
US5722424A (en) * 1995-09-29 1998-03-03 Target Therapeutics, Inc. Multi-coating stainless steel guidewire
JPH09169635A (ja) * 1995-12-20 1997-06-30 Sekisui Chem Co Ltd 経皮吸収製剤
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
DE69926017T2 (de) * 1998-04-27 2005-12-22 SurModics, Inc., Eden Prairie Bioaktive Wirkstoffe freisetzende Beschichtungen
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6325807B1 (en) * 1999-06-11 2001-12-04 Scimed Life Systems, Inc. Variable strength sheath
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US6517520B2 (en) * 2000-12-21 2003-02-11 Ethicon Endo Surgery, Inc. Peripherally inserted catheter with flushable guide-tube

Also Published As

Publication number Publication date
US8158613B2 (en) 2012-04-17
HK1056311A1 (en) 2004-02-13
CA2413699A1 (en) 2002-01-03
NO20026171D0 (no) 2002-12-20
HUP0301121A3 (en) 2006-07-28
EP1296652A1 (en) 2003-04-02
MXPA02012666A (es) 2004-07-30
NO20026171L (no) 2003-02-10
IL153665A0 (en) 2003-07-06
US20030138503A1 (en) 2003-07-24
AU2006202479A1 (en) 2006-07-06
CA2413699C (en) 2010-10-12
US20100273760A1 (en) 2010-10-28
EP1296652B1 (en) 2009-04-29
JP2004501185A (ja) 2004-01-15
CN1438878A (zh) 2003-08-27
EP2027851A1 (en) 2009-02-25
BR0112356A (pt) 2003-05-06
DK1296652T3 (da) 2009-08-17
NO333292B1 (no) 2013-04-29
ZA200210224B (en) 2003-06-18
US20080166413A1 (en) 2008-07-10
US7754240B2 (en) 2010-07-13
AU2006202479C1 (en) 2010-06-10
PL360868A1 (en) 2004-09-20
ES2325980T3 (es) 2009-09-28
AU2006202479B2 (en) 2009-08-20
DE60138547D1 (de) 2009-06-10
GB0015617D0 (en) 2000-08-16
PL211890B1 (pl) 2012-07-31
WO2002000203A1 (en) 2002-01-03
KR20030041871A (ko) 2003-05-27
HUP0301121A2 (hu) 2003-09-29
AU2001267686A1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
ATE144704T1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE69815122D1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
BR9509853A (pt) Formulação farmacêutica uso da mesma e processos para fabricar a mesma para tratar um paciente em necessidade de tratamento anti-trombótico para tratar tromboembolismo e para intensificar a absorção do composto terapeuticamente ativo
NO925038L (no) Anordning for nedsettelse av medikamentets hudirriterendevirkninger
ATE99932T1 (de) Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis.
ATE267583T1 (de) Arzneizubereitungen zur behandlung sexueller funktionsstörungen
DE3685696D1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DK1343472T3 (da) Thixotropisk næsespray
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
Dhaon et al. Efficacy and Safety of Nimesulide Transdermal Gel versus Diclofenac and Piroxicarn Gel in Patients with Acute Musculoskeletal Condition
James Neuropathy: Call for info. on Voltaren Emulgel (topical diclofenac sodium)
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1296652

Country of ref document: EP